ConductScience.org, home

Paper69411

Results at 5 years of a controlled comparison of a 6-month and a standard 18-month regimen of chemotherapy for pulmonary tuberculosis.

Am Rev Respir Dis, 1977. Cited by 24 papers, by iCite.

Cite this record

ConductScience Library. Results at 5 years of a controlled comparison of a 6-month and a standard 18-month regimen of chemotherapy for pulmonary tuberculosis. Papers, record 69411. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/69411

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Results at 5 years of a controlled comparison of a 6-month and a standard 18-month regimen of chemotherapy for pulmonary tuberculosis.
PubMed
Journal
Am Rev Respir Dis
PubMed
Year
1977
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
0.7
iCite
Revised in PubMed
2013-11-21
PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Tuberculosis, PulmonaryMajor topic
Drug Therapy, Combination
Humans
Isoniazid
Patient Dropouts
Recurrence
Rifampin
Streptomycin
Thioacetazone
Time Factors

Source PubMed

Download CSV of topics

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
31981713High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial.Contemp Clin Trials2020https://conductscience.org/library/papers/31981713PubMed
28629333Efficacy of ultra-short course chemotherapy for new smear positive drug susceptible pulmonary tuberculosis: study protocol of a multicenter randomized controlled clinical trial.BMC Infect Dis2017https://conductscience.org/library/papers/28629333PubMed
24659544Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.Eur Respir J2014https://conductscience.org/library/papers/24659544PubMed
24454706Potential cost-effectiveness of a new infant tuberculosis vaccine in South Africa--implications for clinical trials: a decision analysis.PLoS One2014https://conductscience.org/library/papers/24454706PubMed
21269503Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study.BMC Public Health2011https://conductscience.org/library/papers/21269503PubMed
20975714A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy.Nat Commun2010https://conductscience.org/library/papers/20975714PubMed
16911786Impact of DOTS expansion on tuberculosis related outcomes and costs in Haiti.BMC Public Health2006https://conductscience.org/library/papers/16911786PubMed
10160073Cost effectiveness of antituberculosis interventions.Pharmacoeconomics1995https://conductscience.org/library/papers/10160073PubMed
7698121Chemotherapy of lepromatous leprosy: recent developments and prospects for the future.Eur J Clin Microbiol Infect Dis1994https://conductscience.org/library/papers/7698121PubMed
7530627Current and potential treatment of tuberculosis.Drugs1994https://conductscience.org/library/papers/7530627PubMed
6749471Short-course therapy for tuberculosis.Drugs1982https://conductscience.org/library/papers/6749471PubMed
3836965Short course chemotherapy for tuberculosis in children.Indian J Pediatr1985https://conductscience.org/library/papers/3836965PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Authors
  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/69411

GET https://conductscience.org/api/papers/v1/69411/authors